Why You Can't Sleep on Peptides

Your body does not wake you up at 2 or 3 in the morning because sleep is broken. It wakes you up because it thinks you are dying.

That sounds dramatic, but the mechanism is straightforward. Blood glucose dropping below a certain threshold triggers a hormonal rescue response, and that response involves cortisol and adrenaline. Both of those are alerting hormones. Their job is to get you moving and get glucose back into circulation, and they are very good at that job. Good enough to pull you completely out of sleep.

So when someone starts a peptide protocol and suddenly cannot stay asleep past 3am, the instinct is to blame the peptide for disrupting sleep architecture. But the peptide is not touching your sleep architecture. It is touching your blood sugar, and your blood sugar is setting off the alarm.

To understand why, you need to understand what your body is managing overnight.

When you stop eating for the night, your liver starts releasing stored glucose to keep your brain and organs fueled. This works fine under normal conditions. Your body has enough stored fuel, your insulin is low, and your liver trickles glucose out steadily until morning. The whole system runs quietly in the background while you sleep.

Peptides can disrupt two different points in that system, and the disruption depends on which class of peptide you are using.

The first class is something called incretin mimetics, which are compounds like semaglutide, tirzepatide, and retatrutide that mimic gut hormones your body naturally releases after eating to signal fullness and slow digestion. These drugs are extraordinarily effective at suppressing appetite. In a 2023 phase two trial, retatrutide at the 12mg dose produced a mean weight loss of 24.2 percent over 48 weeks, which is a number that would have seemed impossible for a drug just a decade ago.

But that appetite suppression does not care what time it is. People on these compounds often eat far less than they realize throughout the day, not because they are being disciplined but because they genuinely are not hungry. Less food going in means less glycogen stored in the liver going into the night. Less glycogen means less runway before blood glucose starts to drop. And if it drops far enough while you are sleeping, the rescue response fires.

The second class is something called GH secretagogues, which are compounds like CJC-1295, ipamorelin, and tesamorelin that stimulate your pituitary gland to release pulses of growth hormone. Most protocols call for injecting these at night before bed, because that aligns with your body's natural GH release pattern and maximizes the anabolic effect during sleep.

The problem is that growth hormone is anti-insulin. That is not a side effect or a flaw. That is part of how it works. Growth hormone directs your body toward fat burning and away from glucose use, which requires it to blunt insulin's ability to drive glucose into cells. The mechanism involves increasing circulating free fatty acids, which the muscles preferentially use for fuel and which simultaneously interfere with insulin signaling at the cellular level.

Research published in Endocrine Reviews documented this clearly: GH antagonizes insulin's effects at both the liver and peripheral tissues through this free fatty acid mechanism, raising blood glucose as a direct consequence of the GH pulse.

There is a clinical phenomenon that illustrates this perfectly, something called the dawn phenomenon, which is the early morning blood sugar rise that many people with diabetes experience. Research showed that this rise is caused specifically by the nocturnal growth hormone spike. When researchers used a drug to suppress those GH spikes overnight in people with type 1 diabetes, the dawn phenomenon disappeared entirely. When they restored the GH spikes, it came back. And with the spikes present, hepatic glucose production increased by roughly 30 percent compared to baseline.

That 30 percent increase matters. The liver is already trying to maintain your blood glucose overnight. GH tells the liver to dump significantly more glucose than usual. In someone who ate a normal day of food, that may just mean slightly elevated fasting glucose. In someone who barely ate because their incretin drug crushed their appetite, the swing can go in both directions and the body overcorrects into the low range, which is exactly when the cortisol alarm fires.

This is why stacking both classes creates the worst situation. The incretin has reduced your fuel reserves going into the night, and the GH secretagogue is creating glucose swings on top of that deficit.

The fix follows directly from the mechanism.

If you are on an incretin and undereating, the solution is not a supplement or a timing trick. It is making sure you are actually consuming enough food during the day even when the drug is telling you not to be hungry. This is one of the underappreciated risks of powerful appetite suppression. The drug works so well that people forget their body still has a minimum calorie requirement to function through the night.

If you are eating low carb or keto, gluconeogenesis, which is your liver's ability to manufacture glucose from protein and fat rather than carbohydrate, will compensate if you are eating enough total calories. The issue is not the absence of carbs. The issue is total caloric deficit severe enough that there is not enough substrate for the liver to work with.

If you are on a GH secretagogue and experiencing the blood sugar swings, shifting your injection two to three hours earlier in the evening, rather than right before bed, gives the GH pulse time to play out before your deepest sleep phase when the cortisol response will be most disruptive. A small protein and fat snack close to bed can also provide the liver with substrate and slow the glucose drop, which raises the threshold before the rescue response triggers.

Most people troubleshooting sleep on peptides are trying to fix a sleep problem that does not exist. The sleep system is responding exactly as it should to a metabolic signal. Fix the signal, and the sleep fixes itself.

---

References

1. Perriello G, De Feo P, Torlone E, et al. Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in Type 1 diabetes mellitus by decreasing hepatic and extrahepatic sensitivity to insulin in the absence of insulin waning. Diabetologia. 1990;331:52-59. Finding: Suppressing nocturnal GH spikes with somatostatin abolished the dawn phenomenon; restoring GH spikes reproduced it. Hepatic glucose production increased approximately 30%. Source
2. Moller N, Jorgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine Reviews. 2009;302:152-177. Finding: GH antagonizes insulin's hepatic and peripheral effects via increased free fatty acid flux and uptake. Source
3. Jastreboff AM, Kaplan LM, Frias JP, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity: A Phase 2 Trial. New England Journal of Medicine. 2023;3896:514-526. Finding: 24.2% mean weight loss at 12mg dose; significant appetite suppression documented across all dose groups. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness